NCT00280358已完成1 期
A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator.
Dey2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2006年1月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Levels of study medication in blood and urine.
研究概览
简要总结
The purpose of the study is to obtain initial pharmacokinetic data in healthy patients after dosing a combination of the study medications.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Non-smokers, BMI 18-29, no current medications
排除标准
- •Significant conditions or disease
结局指标
主要结局
Levels of study medication in blood and urine.
次要结局
- Safety/tolerability
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
A Study to Investigate in Healthy Volunteers (Part 1) and in Patients With Type 2 Diabetes Mellitus (Part 2) the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of RO6799477Healthy Volunteer, Type 2 DiabetesNCT02164266Hoffmann-La Roche40
已完成
1 期
A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of MaravirocHIV InfectionHIV-1 InfectionMycobacterium Avium Complex (MAC)NCT01894776Ottawa Hospital Research Institute15
已完成
1 期
TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278HIV InfectionsNCT01031589Tibotec Pharmaceuticals, Ireland19
已完成
1 期
Study to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and NintedanibDrug InteractionsNCT06717100PureTech24
已完成
1 期
Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy SubjectsIschemic StrokeAcute Coronary SyndromeNCT06584812Tianjin Institute of Pharmaceutical Research Co., Ltd14